Company Financials

Samsung Biologics Co.,Ltd. Financials

South Korean won

business Samsung Biologics Co.,Ltd. Company Profile

Main Stock Listing

KRX: 207940

Market Capitalization ₩77.908 Trillion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 110.57
Forward PE 42.44
Price to Sales TTM ₩14.15
Price to Book MRQ ₩6.40
Enterprise to Revenue 14.12
Enterprise to EBITDA 28.91

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 28.99%
Operating Margin 43.90%
Return on Assets TTM 7.34%
Return on Equity TTM 14.02%

Income Statement

Revenue TTM ₩5,504,838,402,048
Revenue per Share TTM ₩118918.24
Quarterly Revenue Growth 39.90%
Gross Profit TTM ₩3,077,817,761,792
EBITDA ₩2,817,966,227,690
Net Income to Common TTM ₩1,595,893,088,256
Diluted EPS TTM ₩15221.00
Quarterly Earnings Growth YoY 117.20%

Balance Sheet

Total Cash MRQ ₩1,960,050,032,640
Total Cash per Share MRQ ₩42341.97
Total Debt MRQ
Total Debt to Equity MRQ 10.03
Current Ratio MRQ 1.69
Book Value per Share MRQ ₩263099.23

Cash Flow

Operating Cash Flow TTM ₩2,215,215,366,144
Levered Free Cash Flow TTM ₩452,587,978,752

207940 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 46,290,950
Float Shares 11,830,115
Avg 10 Volume 36,130
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 74.40%
% Held by Institutions 14.10%

Stock Price Summary

Beta 0.20
Fifty Two Week Low ₩1432983.50
Fifty Two Week High ₩1944983.00
Fifty Two Week Change 13.58%
Day 50 MA ₩1772557.10
Day 200 MA ₩1637420.40

Dividends and Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate
Trailing Annual Dividend Yield %
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2025-10-30